Physiomics uses Virtual Tumour and other industry standard technologies to predict the effects of cancer treatment regimes for the biopharma industry.
How can we help you?
Solve cancer drug development challenges
Optimise combination regimens, manage drug resistance, scale up from mouse to human, predict immune-oncology effectsLearn more
See our range of cancer modelling experience
Find out more about drug targets, drug types and cell lines where we have significant experienceLearn more
Learn about Virtual Tumour
Flexible in-silico cell-cycle based model combining PK and PD effects to predict cancer growth inhibition.Learn more
Any other questions?
If you don’t see what you need here, please contact us by clicking on the link below.Contact Us